Given that inappropriate IFN pathway hyperactivation may underlie diseases of premature aging (110), it is reasonable to hypothesize that aging-associated neurodegenerative diseases are also driven, in part, by augmented IFN signaling. The gene discussed is IFNA1; the disease is neurodegenerative disease.